Double Valve Infective Endocarditis Presenting with Acute Ischemic Stroke
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2015, Vol 2, Issue 2
Abstract
Infective endocarditis is a potentially fatal infectious disease which usually presents with various clinic scenarios. Although the disease generally presents itself with fever, cardiac murmur (bruit), splenomegaly and anemia; in this case we report a double valve endocarditis of a 23 years-old female patient who was admitted to our neurology clinic with acute ischemic stroke.
Authors and Affiliations
Mehmet Ugurlu, Bahadir Sarli, Ahmet Oguz Baktir, Fazilet Sag Erturk
Keywords
Related Articles
- EP ID EP231537
- DOI 10.17352/2455-2976.000016
- Views 93
- Downloads 0
Cardiac Myxomas - Symptomology, Investigations and Surgical Treatment - Single Centre Experience of Fifteen Years at Grant Medical College, Mumbai, Maharashtra
Introduction: The aim of study is to describe the clinical symptoms, investigation findings and surgical treatment of cardiac myxomas. Method: From May 2002 to May 2017, 50 patients of primary or recurrent intracardiac m...
Pathological Biomineralization in the Calcific Aortic Valve
The prevalence of moderate to severe calcific aortic valve stenosis in patients ≥75 years old is 2.8% and only 40% of patients with surgical indication undergo aortic valve replacement because of high perioperative risk,...
Vascular complications of infective endocarditis in Burkina Faso
Introduction: Vascular complications of infective endocarditis are frequent and severe. The aim of this study was to clarify the epidemiological, clinical and prognostic characteristics of these vascular damages and dete...
Troponin Levels in Patients in Acute Phase of Stroke
Background and Purpose: The purpose of this study was to assess the correlation of cTn levels in the acute phase of ischemic stroke with the extent of stroke, the degree of disability assessed on the modified Rankin Scal...
Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
Background: We compared the angiotensin receptor–neprilysin inhibitor LCZ696 (sacubitril/valsartan) with enalapril in patients who had nonischemic heart failure with a reduced ejection fraction. Methods: In this double-...